263 related articles for article (PubMed ID: 6122483)
1. Adrenergic mechanisms in control of plasma lipid concentrations.
Day JL; Metcalfe J; Simpson CN
Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483
[TBL] [Abstract][Full Text] [Related]
2. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
Day JL
Wien Med Wochenschr; 1982; 132 Spec No 2():19-22. PubMed ID: 6132497
[No Abstract] [Full Text] [Related]
3. The effect on HDL cholesterol of oxprenolol and atenolol.
Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic mechanisms in the control of plasma lipids in man.
Day JL; Metcalfe J; Simpson N; Lowenthal L
Am J Med; 1984 Feb; 76(2A):94-6. PubMed ID: 6142647
[TBL] [Abstract][Full Text] [Related]
5. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic administration of propranolol on lipoprotein composition.
Tanaka N; Sakaguchi S; Oshige K; Niimura T; Kanehisa T
Metabolism; 1976 Oct; 25(10):1071-5. PubMed ID: 184363
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of sotalol on plasma lipids.
Lehtonen A; Viikari J
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():405s-407s. PubMed ID: 232028
[TBL] [Abstract][Full Text] [Related]
9. The emerging problem of plasma lipid changes during antihypertensive therapy.
Johnson BF
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
[TBL] [Abstract][Full Text] [Related]
10. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
11. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
[TBL] [Abstract][Full Text] [Related]
12. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
[TBL] [Abstract][Full Text] [Related]
13. Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol.
Sane T; Nikkilä EA; Taskinen MR; Välimäki M; Ylikahri R
Atherosclerosis; 1984 Nov; 53(2):185-93. PubMed ID: 6517974
[TBL] [Abstract][Full Text] [Related]
14. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
Dimmitt SB; Williams PD; Croft KD; Beilin LJ
Clin Sci (Lond); 1998 Jun; 94(6):573-8. PubMed ID: 9854453
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
[TBL] [Abstract][Full Text] [Related]
16. [Antihypertensive therapy and lipid metabolism].
Krone W; Müller-Wieland D; Greten H
Klin Wochenschr; 1984 Mar; 62(5):193-202. PubMed ID: 6143851
[TBL] [Abstract][Full Text] [Related]
17. The effects of labetalol and oxprenolol on blood lipids.
Sommers DK; de Villiers LS; van Wyk M; Schoeman HS
S Afr Med J; 1981 Sep; 60(10):379-80. PubMed ID: 7025257
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
Pollare T; Lithell H; Selinus I; Berne C
BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
[TBL] [Abstract][Full Text] [Related]
19. High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
Kuster GM; Amann FW; Neuenschwander C; Drexel H
Cardiovasc Drugs Ther; 2002 Mar; 16(2):127-31. PubMed ID: 12090905
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Durrington PN; Brownlee WC; Large DM
Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
